EPA Hit With 2 Lawsuits Over Safety Review for Chemicals
Earthjustice filed two lawsuits in the U.S. District Court for the Northern District of California yesterday (August 15) that challenge how the Environmental Protection Agency (EPA) performs safety reviews on chemicals that harm families and workers.
The suits specifically focus on the EPA’s Prioritization and Risk Evaluation rules, which were both passed under the Trump Administration to establish how the agency will carry out its jurisdiction under the Toxic Substances Control Act (TSCA).
Per the EPA website, “The Toxic Substances Control Act of 1976 provides EPA with authority to require reporting, record-keeping and testing requirements, and restrictions relating to chemical substances and/or mixtures. Certain substances are generally excluded from TSCA, including, among others, food, drugs, cosmetics and pesticides.” Chemicals covered under TSCA include detergents, household cleaners and asbestos.
Congress overhauled the TSCA in 2016 for the first time. The update, per an article in The Atlantic, expanded the powers of the EPA, giving “teeth” to a law that “ostensibly regulates household and industrial compounds (chemicals in the stuff under the sink or in the garage).” It requires the EPA to conduct comprehensive risk evaluations of chemicals without regard to cost, and with special attention to the risks posed to vulnerable populations, according to Earthjustice.
“After Congress took bipartisan action to make desperately needed updates to our chemical safety laws, the Trump Administration has turned back the clock, leaving families and workers at risk,” said Eve Gartner, an attorney at Earthjustice, in the statement. “This lawsuit is about one thing: holding the Trump EPA to the letter of the law and ensuring it fulfills its mandate to protect the public.”
The lawsuits were filed by Earthjustice on behalf of eight groups, including WE ACT for Environmental Justice, Learning Disabilities Association of America and the Union of Concerned Scientists. Read the two complaints here and here.
Looking for chemical products? Let suppliers reach out to you!
2026-07-17
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Plant Omega-3 Gets a New Argument
-
EPA releases draft Biological Opinion of Methomyl: 82 species may be threatened
-
The U.S. EPA adjusted the concentration limit for Atrazine to 9.7µg/L for aquatic organisms
-
The US EPA issued new regulations for Chlorpyrifos, and Corteva and Gharda voluntarily canceled many products
-
The US EPA intends to register a new herbicide active ingredient, Glufosinate-P
-
The U.S. Environmental Protection Agency (EPA) has proposed to ban Acephate and keep it for injectable use only in trees
-
Federal Appeals Court Overturns EPA Ban on Chlorpyrifos for Food Crops
-
U.S. Regulators Review Chemical Found in Tires That Harms Salmon, Prompting Calls for Ban
-
Court rules EPA must regulate Perchloate
-
Basf's herbicides Beyond and Raptor will be sold in the U.S. under the brand name Beyond Xtra
Recommend Reading
-
关于将二氟乙咪酯等16种物质列入《非药用类麻醉药品和精神药品目录》的公告 Announcement on the Inclusion of 16 Substances including Difluoroetomidate in the Catalogue of Non-Medicinal Narcotic Drugs and Psychotropic Substances
-
关于全面排查下架易制毒及易制爆产品信息的公告 Announcement on the Comprehensive Review and Removal of Product Information Related to Precursor and Explosive Precursor Chemicals
-
关于加强防范钓鱼邮件的通知 Notification on Strengthening Anti-Phishing Measures
-
“全球展会数据”功能上线公告 Announcement on the Launch of the “Global Exhibition Data” Function
-
关于将4-amino-1-boc-piperidine、tert-buty 4-aminopiperidine-1-carboxylate产品列入《ECHEMI平台禁限售商品目录》的公告 Announcement on Including 4-amino-1-boc-piperidine and tert-buty 4-aminopiperidine-1-carboxylate in the Announcement on the List of Prohibited Sales of Prohibited and Controlled Items on ECHEMI
-
Ethylene Glycol Prices Stabilize and Stop Declining in Mid-to-Early July
-
Coke Market in October Showed Strong Performance with Price Increases Implemented
-
Eli Lilly Strikes $1.3 Billion AI Deal with Superluminal for Next-Gen Obesity Drugs Targets GPCR Breakthrough
-
Chinese Urea Market Shows Weak Downward Trend (7.1-7.9)
-
October MTBE Market Trend Fluctuates and Declines in China